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Abstract
Background: Early events leading to intrauterine infection and fetal lung injury remain poorly defined, but may hold the key
to preventing neonatal and adult chronic lung disease. Our objective was to establish a nonhuman primate model of an
early stage of chorioamnionitis in order to determine the time course and mechanisms of fetal lung injury in utero.
Methodology/Principal Findings: Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118–125 days
gestation (term=172 days) received one of two treatments: 1) choriodecidual and intra-amniotic saline (n=5), or 2)
choriodecidual inoculation of Group B Streptococcus (GBS) 1610
6 colony forming units (n=5). Cesarean section was
performed regardless of labor 4 days after GBS or 7 days after saline infusion to collect fetal and placental tissues. Only two
GBS animals developed early labor with no cervical change in the remaining animals. Despite uterine quiescence in most
cases, blinded review found histopathological evidence of fetal lung injury in four GBS animals characterized by intra-
alveolar neutrophils and interstitial thickening, which was absent in controls. Significant elevations of cytokines in amniotic
fluid (TNF-a, IL-8, IL-1b, IL-6) and fetal plasma (IL-8) were detected in GBS animals and correlated with lung injury (p,0.05).
Lung injury was not directly caused by GBS, because GBS was undetectable in amniotic fluid (,10 samples tested/animal),
maternal and fetal blood by culture and polymerase chain reaction. In only two cases was GBS cultured from the inoculation
site in low numbers. Chorioamnionitis occurred in two GBS animals with lung injury, but two others with lung injury had
normal placental histology.
Conclusions/Significance: A transient choriodecidual infection can induce cytokine production, which is associated with
fetal lung injury without overt infection of amniotic fluid, chorioamnionitis or preterm labor. Fetal lung injury may, thus,
occur silently without symptoms and before the onset of the fetal systemic inflammatory response syndrome.
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Introduction
Preterm birth and the resulting neonatal morbidity and
mortality represent a significant public health and economic
burden to our society [1]. Intrauterine infection is present in most
cases of the earliest preterm births and incites an inflammatory
response believed to result in preterm labor and fetal lung injury
[2]. Biological mechanisms initiating and propagating inflamma-
tion, preterm birth and fetal lung injury remain ill-defined and
represent a major barrier to finding an effective treatment. The
currently accepted paradigm is that bacteria ascend from the lower
genital tract and sequentially colonize the choriodecidual space
(external to the membranes and amniotic fluid) followed by
trafficking into the amniotic fluid. Bacteria then induce cytokines,
including interleukin-1b (IL-1b) and interleukin-8 (IL-8), which
are thought to be a critical trigger of preterm labor and fetal lung
injury predisposing the neonate to chronic lung disease [3,4,5].
Studying early events in microbial invasion of the amniotic
cavity may help determine how a therapeutic might be best
administered to successfully prevent preterm birth. An intramus-
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choriodecidual bacteria and downregulate immune effectors.
Recently, intra-amniotic infection has been suggested as an earlier
step in the process, followed by secondary bacterial colonization of
the fetal membranes (chorioamnion) resulting in chorioamnionitis
[6]. If this scenario is more typical, then direct administration of a
drug into the amniotic fluid via amniocentesis may be required.
Both microbial and host factors, as well as inoculum size, are likely
to play a role in whether bacterial colonization of the
choriodecidual space results in intra-amniotic infection. In a pilot
study in rhesus macaques, we have shown that Group B
Streptococcus (GBS) inoculated into the choriodecidual space can
traffic into the amniotic fluid, but required large and sometimes
several inoculations [7]. The extent to which a small inoculum or
transient infection might impact the mother or fetus’ health is
unknown, but may reflect the most common event leading to
preterm birth in the setting of intrauterine inflammation [elevated
amniotic interleukin-6 (IL-6)] and a negative amniotic fluid culture
[8,9,10,11].
Controversy also exists as to whether inflammation in the fetal
membranes (chorioamnionitis) is associated with the most
common form of neonatal chronic lung disease, bronchopulmo-
nary dysplasia (BPD) [12,13]. Although infection and inflamma-
tion can incite lung injury, the inflammatory response may also be
protective by accelerating lung maturation and surfactant
production. A recent meta-analysis of more than 15,000 subjects
concluded that the pooled adjusted odds ratio for an association
between BPD and chorioamnionitis was 1.58 (95% CI 1.1–2.2)
[14]. Considerable study heterogeneity and publication bias,
however, prevented the authors from concluding that chorioam-
nionitis was a definite risk factor for BPD. Understanding the
relationship between inflammation and fetal lung injury has
greater significance, because the prevalence of BPD is increasing,
particularly in very immature infants who may have little or no
evidence of respiratory distress syndrome. This variant has been
called ‘‘new BPD’’ and is thought to be triggered by inflammation
and intrauterine cytokines, which arrest alveolarization and inhibit
growth of pulmonary vasculature [15,16].
To investigate early factors involved in the initiation of
intrauterine inflammation and fetal lung injury, we used a
chronically catheterized pregnant nonhuman primate model
(pigtail macaque; Macaca nemestrina). The nonhuman primate
shares many important features with human pregnancy including
uterine anatomy, singleton gestation, hemochorial placentation,
and microbial communities within the vagina. We infused GBS,
an organism known to cause preterm birth and neonatal invasive
disease [17,18], into the choriodecidual space via a catheter placed
between the uterine muscle and membranes (external to amniotic
fluid) overlying the lower uterine segment. We performed
Cesarean section in the first week after choriodecidual inoculation
to study early events associated with intrauterine infection.
Results
Uterine Activity
The mean gestational age of inoculation was 136 days (range:
131–139 days) and delivery was 141 days from conception (range:
134–145 days) corresponding to approximately 80% of a typical
M. nemestrina pregnancy in our colony delivering at 172 days. Prior
to GBS or saline inoculation, the uterus was quiescent in all
animals. Peak uterine activity after inoculation was not signifi-
cantly different between GBS and saline groups, but two GBS
animals developed labor based on the finding of cervical change
associated with more intense contractions (Table 1). In one case, a
building contraction pattern (4,000–5,000 mmHgNsec/hr) and
cervical change prompted Cesarean section three days after
GBS infusion. In the second animal, slow cervical change occurred
in the setting of episodic contractions. No cervical change or
Table 1. Uterine Activity, Cytokines and Prostaglandins.
Measure Post-inoculation Peak p-value
Saline (n=5) GBS (n=5)
Uterine activity (mmHgNsec/hr) 1,533.4 (880.6) 2,453.5 (2,362.5)
{ 0.70
Amniotic Fluid (ng/ml)
IL-1b 0.004 (0.006) 0.1 (0.2) 0.04*
TNF-a 0.02 (0.03) 0.6 (0.7) 0.01*
IL-6 9.9 (4.8) 72.6 (34.3) 0.003*
IL-8 1.3 (0.6) 13.0 (9.9) 0.001*
PGE2 0.6 (0.8) 0.7 (0.7) 0.71
PGF2aa 0.6 (0.4) 1.2 (1.3) 0.48
Total MMP activity (pmol/min) 25.9 (5.3) 29.1 (11.6) 0.59
Fetal Plasma (pg/ml)
IL-1b 0.0 (0.0)
{ 0.0 (0.0) -
TNF-a 0.7 (1.2)
{ 0.1 (0.2) -
IL-6 1.8 (0.8)
{ 4.9 (4.5) 0.06
IL-8 309.5 (186.3)
{ 1,569.2 (1,081.2) 0.03*
Table presents the mean (SD). Values for amniotic fluid analyses are ng/ml or pmol/min (MMP activity) and for fetal analyses are pg/ml. P-values are based on ANOVA
models fit on log-transformed data except total MMP activity, which did not require log transformation.
*p,0.05.
{N=4 for uterine activity in GBS group due to technical issues and insufficient data collection in one case.
{N=3 for fetal plasma of saline controls.
doi:10.1371/journal.pone.0028972.t001
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any saline controls.
Cultures and GBS PCR
Cultures of the amniotic fluid and fetal membranes, lungs,
blood and cerebrospinal fluid were performed to correlate findings
with bacterial trafficking (Table 2). Culture of the chorioamnion at
the inoculation site revealed low-level GBS [100–1,000 colony
forming units/milliliter (CFU)] in two cases; one animal had no
evidence of labor and the second had slow cervical change with
episodic contractions. The inoculation site was culture negative in
the other GBS animal in labor. Cultures of the amniotic fluid (,10
samples tested/animal) and fetal tissues were negative in all
animals, with the exception of suspected contaminants in a few
cases (e.g. Streptococcus viridans). To determine whether low levels of
GBS might be present in the amniotic fluid that was not detected
by culture, quantitative real-time PCR was performed on serially
sampled amniotic fluid at three points in the course of the
experiment including the day prior to inoculation, day of Cesarean
section and once during the course of the experiment. All amniotic
fluid samples were negative with the lower limit of assay detection
being 10 copies per PCR reaction.
Fetal Lung Injury
A representative fetal lung section from a GBS and saline
control animal is shown in Figure 1. Fetal lung histology was
scored on a scale of 0 (normal) to 4 (severe injury) by a board
certified veterinary pathologist (H.D.L.) blinded to group
assignment as previously reported [19]. There was evidence of
fetal lung injury in four of the five GBS animals (lung scores=2,
3, 3, and 4), as well as one control (lung score=2). Fetal lung
injury varied in severity and distribution. Injury was defined as an
aggregate of histologic changes including accumulation of
inflammatory cells, evidence of necrosis, inflammatory related
tissue thickening, collapse or other injury such as fibrin exudation
or hemorrhage. The distribution of injury varied with severity but
involved vascular and perivascular compartments as well as
airway and alveolar compartments. In one control, fetal lung
injury was an infarction of a lung tip and appeared histologically
very different from controls and GBS lungs. In this case,
hemorrhage was the predominant finding and thought to have
occurred peri-mortem.
Inflammatory cells observed in the fetal lungs from GBS group
included high numbers of neutrophils and macrophages, which is
consistent with the pattern described in preterm infants at different
stages of developing BPD [20]. In addition, there was increased
staining density and thickened septa that was absent in saline
controls. The most severe cases of fetal lung injury (fetal lung
scores=3, 3, and 4) correlated with the highest levels of amniotic
fluid and fetal IL-8, but not other cytokines or prostaglandins
tested (Table 1).
Cytokines, Prostaglandins, and MMP
Temporal relationships between uterine activity, amniotic fluid
cytokines and prostaglandins are depicted in one animal after
GBS inoculation with moderate fetal lung injury and minimal
uterine activity and a representative saline control (Figure 2).
Saline infusion in either the choriodecidual space or the amniotic
fluid of controls was not associated with an elevation in amniotic
fluid cytokines. Following GBS choriodecidual infusion, amniotic
fluid IL-1b, IL-8, IL-6 and TNF-a increased significantly
compared to controls (Table 1; all p,0.05). GBS inoculation
was not associated with a significant change in amniotic fluid
prostaglandins or total matrix metalloproteinase activity during
this four day experiment.
In two controls, fetal samples for cytokine analysis were not
obtained due to either an inability to place the fetal catheter or
clotting of the catheter. Fetal plasma IL-8 was significantly higher
in GBS animals versus controls and correlated best with fetal lung
injury of the fetal cytokines measured (p=0.03). The GBS animal
with the greatest degree of fetal lung injury (lung score=4) also
developed preterm labor and had a fetal IL-6 level of 11.3 pg/ml,
which is diagnostic of the fetal systemic inflammatory response
syndrome (FIRS) in humans [21]. In the other three GBS animals
with fetal lung injury, the fetal IL-6 level (2.6, 3.1, 7.5 pg/ml) was
below the threshold for FIRS. Fetal plasma IL-1b was undetect-
able in all but one animal and fetal plasma TNF-a was
undetectable in all but two animals.
Table 2. Amniotic Fluid and Fetal Cultures.
Group AF Membrane Fetal Meninges Fetal Lung Fetal CSF Fetal blood
Inoculation site Fundus
Saline 1 None None None None None None None
Saline 2 None* None None None None None None
Saline 3 None None None None None None None
Saline 4 None* None None None None None None
Saline 5 None None None None None None None
GBS 1 None* None None None None None None
GBS 2 None None None None None None None
GBS 3 None None None None None None None
GBS 4 None 1,000 GBS, ,100 S. aureus None None None None None
GBS 5 None 100 GBS None None* None* None None
Above values represent CFU/ml.
*A suspected contaminant (coagulase negative Staphylococcus, S. viridians) was noted in one AF culture of two saline controls and one GBS animal with all subsequent
cultures being negative. Multiple suspected contaminants were noted in fetal tissue cultures from GBS #5 collected at the time of necropsy by an ill pathologist, who
was coughing and wearing a mask (e.g. Streptococcus gordonii, Neisseria species).
AF, amniotic fluid; CSF, cerebrospinal fluid.
doi:10.1371/journal.pone.0028972.t002
Fetal Lung Injury After Choriodecidual Infection
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28972Placental Histopathology
Histopathology of the chorioamnion was reviewed by a
pathologist (R.P.K.) blinded to group assignment. Representative
tissues are shown in Figure 3 and results correlated with fetal lung
score and labor in Table 3. Chorioamnionitis was diagnosed in
two GBS animals with evidence of fetal lung injury (lung scores=4
and 2); only one of these animals was in labor. Funisitis
(inflammation of the umbilical cord) also occurred in one case,
which correlated with the lung score of four. As previously noted,
GBS was not detected in the amniotic fluid by either culture or
PCR. Normal placental histology was noted in all controls and the
remaining three GBS animals, two of which had signs of moderate
fetal lung injury (lung score=3 in both cases). In one GBS animal
with fetal lung injury and a final diagnosis of normal histology,
there were very rare scattered degenerating neutrophils within the
membranes; this finding was subtle and not sufficient for making
the diagnosis of chorioamnionitis.
Discussion
Our study objective was to determine early biological events in
choriodecidual infection and temporal relationships between
bacterial trafficking, chorioamnionitis and fetal lung injury. We,
therefore, performed Cesarean section a few days after initial
inoculation and in the absence of labor in all but two cases.
Despite relative uterine quiescence and minimal numbers of GBS
organisms cultured from membranes at the inoculation site,
significant fetal lung injury was detected in four of five animals just
four days after choriodecidual inoculation. The lung injury could
not be attributed to live bacteria, because amniotic fluid cultures
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Figure 1. Histopathology of the fetal lungs. Hematoxylin and eosin stained histologic sections of fetal lung are shown for a saline control (A;
lung score=0) and GBS animal with severe fetal lung injury (B; lung score=4).
doi:10.1371/journal.pone.0028972.g001
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injury may occur silently, predisposing the neonate to broncho-
pulmonary dysplasia, without presenting any warning signs to the
obstetrician until the relatively late development of preterm labor.
Elevation of amniotic fluid cytokines in GBS animals of our study
is consistent with the hypothesis of others that aspiration of
inflammatory mediators from the amniotic fluid is a key factor
contributing to the fetal lung injury leading to BPD, the leading
cause of chronic lung disease in infancy in the United States
[5,16,22,23,24]. Our study extends this work by revealing that fetal
lung injury may occur without clinical signs or symptoms of preterm
labor and no microbiologic or pathologic evidence of infection. This
suggests that a placental or membrane immune response may clear
a choriodecidual infection to allow the pregnancy to continue, but
results in production of inflammatory mediators that induce fetal
lung injury in a paracrine response (Figure 4). This may occur
through diffusion of inflammatory mediators into the amniotic fluid
and direct contact with fetal lungs or via diffusion into fetal blood at
the maternal-fetal interface [25,26]. The mechanisms involved in
the pathway linking antenatal inflammation and chorioamnionitis
to fetal lung injury remain unclear.
How fetal lung injury is initially mediated has not been explored
previously, because amniotic fluid and cord blood samples are
generally collected at the time of preterm labor and delivery,
which our study suggests may be quite late in the process. The
relatively low levels of fetal plasma cytokines in most GBS animals
with fetal lung injury suggest that in the early stages, fetal lung
injury may be more likely to occur through direct contact of the
fetal lung with inflammatory mediators in the amniotic fluid. In
one animal receiving two GBS inocula, an elevated fetal plasma
IL-6 (11.3 pg/ml) meeting criteria for FIRS occurred; this level of
fetal IL-6 has been reported to better predict BPD than
inflammatory mediators in the amniotic fluid [27,28]. However,
marked fetal lung injury was noted in three other GBS animals
despite fetal IL-6 levels that were fairly low in two cases (2–3 pg/
ml). In contrast, amniotic fluid peak IL-6 levels were relatively
high in all animals with lung injury (range: 77.9–102.6 ng/ml).
Whether an elevated amniotic fluid IL-6 or another inflammatory
mediator initiates fetal lung injury is unknown, but this pattern of
inflammation may be a biomarker for the early stages of fetal lung
injury; interestingly, it also models the clinical condition in up to
25% of preterm labor cases with an elevated amniotic fluid IL-6
and a negative culture and/or PCR result [8,9,10,11]. This
suggests that in utero fetal lung injury of some degree may be much
more common than previously recognized.
TheroleofIL-8asabiomarkerorinitiatorofBPDisalsounclear.
IL-8 is a plausible candidate as a key trigger of injury, because it is a
chemoattractant for neutrophils, which were the predominant
leukocyte in affected fetal lungs. In our study, amniotic fluid and
fetal plasma IL-8 was significantly elevated in the GBS group
Figure 2. Uterine activity and amniotic fluid cytokines. Temporal relationships among inoculation of GBS or saline, uterine activity, and
amniotic fluid (AF) cytokines (TNF-a, IL-8) are shown in a representative animal after saline inoculation (A) and in an animal after GBS inoculation (B),
which developed moderate lung injury in the setting of minimal uterine activity. The x-axis represents gestational age in days ranging from the
vascular implantation surgery until cesarean section. The y-axis is hourly contraction area (HCA; gray bars), or the level of amniotic fluid TNF-a (red
line) or IL-8 (blue line). CD, choriodecidual; AF, amniotic fluid.
doi:10.1371/journal.pone.0028972.g002
Figure 3. Histopathology of chorioamnion. Hematoxylin and eosin stained histologic sections of chorioamnion (fetal membranes) are shown for
a saline control (A) and GBS animal with chorioamnionitis (B). Neutrophils in the chorion are indicated with arrows in panel B, as well as being
abundant in the decidua.
doi:10.1371/journal.pone.0028972.g003
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amniotic fluid IL-8 greater than 10.7 ng/ml, which is a threshold
previously associated with BPD (range: 6.3–27.2 ng/ml) [24]. In a
prior study in rhesus macaques, we have shown that daily infusions
of a single cytokine including IL-8 and others (IL-6, IL-1b, TNF-a)
were associated with neutrophil infiltrates in the fetal lungs; IL-8
and IL-6 infusions were also associated with interstitial lymphocytic
aggregates, but this may have been a function of a longer exposure
duration [29]. In the preterm fetal sheep model, infusion of
recombinant sheep IL-8 induced a fivefold increase in monocytes
and neutrophils, but did not induce lung maturation associated with
arrest of lung development and BPD [30]. Blockade of lipopoly-
saccharide-induced IL-8 signaling (CXCR2 blocker) was also not
effective in decreasing leukocytes in the bronchoalveolar lavage or
cytokines in the fetal lung. These studies in sheep suggest that IL-8
may be more accurately described as a biomarker.
Table 3. Fetal Lung Score, Cytokines and Chorioamnionitis in Each Animal.
Group
Fetal Lung
Score Peak AF Peak Fetal Plasma
Inoculation Site
Culture
Chorio-
amnionitis Labor
IL-6 (ng/ml) IL-8 (ng/ml) IL-6 (pg/ml) IL-8 (pg/ml)
Saline 1 0 8.3 1.0 * * No growth NO NO
Saline 2 2 16.0 1.6 2.0 523.4 No growth NO NO
Saline 3 0 3.0 0.5 * * No growth NO NO
Saline 4 0 10.3 1.6 0.9 182.3 No growth NO NO
Saline 5 0 11.7 1.9 2.4 223.0 No growth NO NO
GBS 1 0 13.8 3.6 0 3,142.8 No growth NO NO
GBS 2 2 102.6 6.3 7.5 558.1 No growth YES YES
GBS 3 3 80.8 8.5 2.6 1,606.5 No growth NO NO
GBS 4 3 88.1 27.2 3.1 1,975.2 1,000 GBS NO NO
GBS 5 4 77.9 19.3 11.3 563.5 100 GBS YES YES
*In these two animals, fetal samples were not obtained.
doi:10.1371/journal.pone.0028972.t003
Figure 4. Our conceptual model. 1. Bacteria from the lower genital tract ascends into the choriodecidual space. 2. Inflammatory mediators (e.g. IL-
8) produced by decidua and/or membranes diffuse into amniotic fluid and the fetal lung. 3. Fetal lung injury is induced by inflammatory mediators. IL,
Interleukin; AF, amniotic fluid.
doi:10.1371/journal.pone.0028972.g004
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dysplasia and degradation of the fetal membrane extracellular matrix
[31,32]. Increased activity of matrix metalloproteinase-9 (MMP-9)
likely plays a role in fetal lung injury, because elevated cord blood
MMP-9 has been correlated with bronchopulmonary dysplasia
severity and oxygen supplementation [33]. We found no changes in
total matrix metalloproteinase activity in the amniotic fluid, which is
consistent with both ex vivo and in vivo data suggesting that increased
matrix metalloproteinase activity is localized within the membranes
and fetus [34,35]. In a pilot study of GBS choriodecidual infection in
rhesus macaques, activeMMP-9 only became elevated in theamniotic
fluid of a single animal after a high dose GBS inoculum that resulted in
preterm labor [36]. In early choriodecidual infection, local production
and conversion to active enzyme within the fetal lungs may be a more
likely mechanism of injury than direct exposure of the fetal lungs to
matrix metalloproteinases in amniotic fluid.
The absence of chorioamnionitis in two cases with fetal lung
injury sheds light on an important controversy surrounding whether
chorioamnionitisisa riskfactorforBPD [14,23,37,38,39].Although
early observational studies suggested an association, a subsequent
cohort found no association [14]. Bronchopulmonary dysplasia
began to be viewed as requiring ‘‘multiple hits’’, which included an
antenatal inflammation component, as well as postnatal factors like
oxidative stress, ventilator injury, and proteases [38]. Likewise,
studies have reported chorioamnionitis to be associated with both
increased production and depletion of surfactant [40]. These
conflicting reports suggest that the degree and duration of
inflammation may be important in determining the outcome on
surfactant production and possibly the outcome of fetal lung injury.
Our results suggest that a normal histologic appearance of the fetal
membranes does not preclude the possibility of a transient
choriodecidual infection that may have triggered fetal lung injury.
As we ended these experiments after four days, it is unclear whether
the fetal lung injury observed would progress or resolve with further
time in utero [41,42]. Only survival studies with measurements of
lung function after birth would address the question of whether this
lung injury develops into a condition similar to human broncho-
pulmonary dysplasia with accelerated lung maturation, disordered
structural development and impaired function.
Animal models have previously been used to model lung injury
often by inducing end-stage disease. In the preterm fetal sheep
model, the time course and major inflammatory effectors of
endotoxin-induced fetal lung injury have been defined [41,43,44].
In contrast, this study focused on early events in lung injury, which
may have significant relevance in investigation directed towards
prevention. A major strength of this work is the use of an animal
model with many similarities to both human pregnancy and fetal
lung development. The nonhuman primate has a singleton fetus
with a long gestational period (160–170 days), hemochorial
placentation, and maternal-fetal inflammatory responses induced
by infection and parturition, which mimic human pregnancy.
Fetal lung injury in our model also occurs in the saccular stage of
fetal lung development, which replicates the timing of human fetal
lung injury leading to neonatal chronic lung disease. Other animal
models (sheep, mice) are in a more advanced stage of lung
development (alveolar) at the time of experimental injury, which
may limit translation of results to human disease. Pulmonary
morphologic and immune features in our model also emulate that
in humans, but differ from many other species [45]. Both humans
and nonhuman primates lack pulmonary intravascular macro-
phages present in the lungs of many species, making their lungs
less susceptible to injury than other species (e.g. sheep, cattle, pigs).
One important study limitation is that microbial invasion of the
amniotic cavity is likely a chronic process and the time course of
infection depends on the organism and inoculum. Our results are
more likely to reflect events associated with an immune response to
a small or limited choriodecidual infection. A second limitation is
that we terminated our experiments at 4 days; thus, we may have
truncated a process leading to further fetal lung injury or
maturation as the repair process begins. Third, the small sample
size for fetal cytokine data in the saline group precluded
confirming a possible association between fetal IL-8 and lung
injury as suggested by our data and prior reports [5,23,46].
Mechanisms initiating and propagating fetal lung injury in utero
are difficult to study after birth due to the many confounding
clinical variables in the intensive care of preterm infants, such as
the use of mechanical ventilation. Further studies at different time
points may elucidate the natural course of fetal lung inflammation
induced by choriodecidual bacteria and provide insight into how
this response potentially contributes to neonatal lung injury.
Additional soluble effectors associated with this process remain to
be defined and could include previously implicated biomarkers of
fetal lung injury including many chemokines (e.g. MCP-1, MIP-
1b) [47], elastase [48], leukotriene B4 [48], fibronectin [49],
MMP-8 [12], MMP-9 [50,51], and complement C5a anaphyla-
toxin [52]. Overall, our model provides a unique opportunity to
study the fetal origins of neonatal chronic lung disease induced by
amniotic fluid inflammatory mediators, which can be triggered by
many types of bacteria.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Research Council and the
Weatherall report, ‘‘The use of non-human primates in research’’.
The protocol was approved by the Institutional Animal Care Use
Committee of the University of Washington (Permit Number:
4165-01). All surgery was performed under general anesthesia and
all efforts were made to minimize suffering.
Animals and Study Groups
Ten chronically catheterized pregnant monkeys (Macaca nemes-
trina) at 118–125 days gestation (term=172 days) received one of
two experimental treatments: 1) choriodecidual and intra-amniotic
saline infusions (n=5), or 2) GBS choriodecidual inoculation
(n=5). Saline infusions were performed separately in the
choriodecidual and amniotic fluid to confirm that saline would
not stimulate cytokine production in either compartment. In two
saline controls, fetal samples were not collected due to either an
inability to place the fetal catheter during initial surgery or clotting
of the fetal catheter. This resulted in three fetal cytokine analyses
in the saline group. In one GBS case, technical problems led to
only intermittent data collection and so the remaining uterine
activity data was excluded for this animal.
In our model, pregnant pigtail macaques were time-mated and
fetal age determined using early ultrasound. The tethered chronic
catheter preparation was used for all in vivo experiments and is a
major breakthrough in studying maternal-fetal immunologic
responses [53,54]. The animal was first conditioned to a nylon
jacket/tether system for several weeks before surgery, which
allowed free movement within the cage, but protected the
catheters. On day 118–125 of pregnancy (term=172 days)
catheters were implanted into the maternal femoral artery and
vein, fetal internal jugular vein, amniotic cavity, and choriodeci-
dual interface in the lower uterine segment (between uterine
muscle and fetal membranes, external to amniotic fluid). Fetal
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implanted. After surgery, the catheters/electrodes were tracked
through the tether system and cefazolin and terbutaline sulfate
were administered to reduce postoperative infection risk and
uterine activity. Both cefazolin and terbutaline were stopped at
least 72 hours before experimental start (,5 half-lives for
terbutaline, 40 half-lives for cefazolin, .97% of both drugs
eliminated). Cefazolin 1 gram was administered intravenously
each day in saline controls to minimize chances of a catheter-
related infection. Experiments began approximately two weeks
after catheterization surgery to allow recovery (,30–31 weeks
human gestation). At our center, term gestation in the non-
instrumented pigtail macaque population averages 172 days.
Uterine Activity, Labor and Delivery
Intraamniotic pressure, fetal heart rate and maternal temperature
were continuously recorded and digitized with a Powerlab System
(AD Instruments, Colorado Springs, CO) connected to an Intel
computer. Amniotic fluid pressure signals were processed after
delivery using custom software to eliminate noise due to respiration or
position changes. The area under each contraction (mmHgNsec/hr)
was summed for each hour allowing calculation of the hourly
contraction area, which is a measure of uterine activity. Labor was
defined as progressive uterine activity associated with cervical
effacement and dilatation. In the GBS group, Cesarean section was
performed when uterine activity exceeded a 12,000 hourly
contraction area for more than two hours and/or cervical change
indicated labor. Cervical exams were performed on all animals the
day prior to inoculation and then daily in the GBS group or every
other day in the saline group until Cesarean section. Cesarean section
was performed in all animals in order to optimize the collection of
intact gestational tissues. In order to study early events following a
choriodecidual infection, a Cesarean section was planned 4 days after
the GBS inoculation. In saline controls the Cesarean section was
performed 7 days after initial inoculation; saline was inoculated twice
(day 0 and day 4) in alternating order into the choriodecidual space
and amniotic fluid. This protocol was chosen to determine if saline
inoculation induced production of inflammatory mediators when
inoculated into either the amniotic fluid or choriodecidual space; no
significant elevation was detected. In one GBS animal with no
cervical change during the experiment, technical difficulties resulted
in insufficient collection of data for analysis of uterine activity.
Pathology and Lung Injury
After cesarean section, fetuses were euthanized by barbiturate
overdose followed by exsanguination and fetal necropsy. Complete
grossandhistopathologicexamination wasperformedon infants and
placentas. The placenta was examined by a board-certified pediatric
pathologist (R.P.K.) and fetal lungs examined by a board-certified
veterinary pathologist (H.D.L.) with the each pathologist blinded to
group assignment. Lung histologic sections were evaluated and
scored, as previously described, using a semi-quantitative scale [19].
Components were scored on a scale of 0–4 (0=normal) for
inflammatory cells, necrosis, and inflammation including tissue
thickening, collapse or other injury (e.g. fibrin exudation). Lung
compartments scored were (1) vascular/perivascular; (2) bronchial/
peribronchial; (3) alveolar wall; and (4) trichrome stain intensity
positivity. Mononuclear inflammatory cells and neutrophils (Leder
stain) within alveolar spaces were counted (5 random 406fields). An
overall severity score was generated.
GBS and Bacterial Cultures
The microbiologist preparing the GBS and performing the
bacterial cultures participates in a laboratory quality assurance
program through the College of American Pathologists (CAP) and
is licensed through the American Society of Clinical Pathologists
(ASCP) and the American Society of Microbiologists (ASM). We
inoculated a clinical isolate of GBS (Type III, COH-1) using
1610
6 of freshly grown mid-log phase bacteria inoculated into the
choriodecidual space of the lower uterine segment. The COH-1
isolate was recovered from a neonate with meningitis and is highly
virulent; it is the same strain used in prior experiments of intra-
amniotic infection and pilot studies of choriodecidual GBS
infection [7,53]. Single colonies of minimally-passaged GBS from
blood agar plates were transferred to sterile Todd Hewitt Broth
and grown overnight. The GBS inoculum was prepared to a
concentration of 10
6 CFU/mL using the McFarland standard and
a spectrophotometer. Bacterial concentration and purity was
confirmed by colony counts on sheep blood agar with an average
inoculum of 4.6610
6 CFU (range: 3.5–6.3610
6). In one GBS
animal, the inoculum was inadvertently administered simulta-
neously with cefazolin. This GBS strain (COH-1) is rapidly killed
by cefazolin, therefore the cefazolin was stopped. Three days later
a second inoculum of GBS was given to the same animal.
Amniotic fluid was collected daily into anaerobic culture vials
and equal volumes were sterilely inoculated in chopped-meat
anaerobic broth as well as streaked for isolation on Brucella H/K
and Chocolate agar plates. An additional volume was added to a
glass microscope slide and allowed to air dry for Gram staining.
Cultures grown anaerobically were placed within anaerobic
culture jars and the anoxic environment was confirmed by aerobic
indicators. Anaerobic plates were read after 5–7 days and
chocolate plates grown under aerobic conditions were read after
72 hours. Any growth was subcultured and characterized
according to established microbiological techniques.
Additional cultures were collected at the end of the experiment
during Cesarean section and fetal necropsy. The maternal
membrane fundus and inoculation site in the choriodecidual
space were swabbed and placed in anaerobic culture tubes.
Cerebral spinal fluid was aspirated in a sterile fashion and
collected in anaerobic culture vials. Fetal lungs and meninges were
sterilely swabbed and placed within anaerobic culture tubes. Fetal
CSF and blood cultures were cultured as conducted with amniotic
fluid. The above swab cultures were streaked for isolation on
Brucella H/K and chocolate agar plates, and then placed in
chopped meat broth for culture and grown according the
procedure described above.
Quantitation of Amniotic Fluid Cytokines, Prostaglandins,
and Matrix Metalloproteinases
Amniotic fluid and maternal and fetal blood were sampled
frequently before (224 and 21 hour) and after GBS inoculation
(+1, +6, +12, +24 hours, and then daily until delivery). Amniotic
fluid and blood samples were centrifuged for 5 minutes at
1200 RPM and the supernatant frozen and stored at 280uC. Prior
to freezing,ethylene diamine tetraacetic acid (EDTA) (8.7 mM) and
indomethacin (0.3 mM) was added to samples saved for cytokine
and prostaglandin quantitation, respectively. Cytokine (IL-1b, IL-6,
IL-8, and TNF-a) levels were determined by Luminex multiplex
technology using commercially available non-human primate
cytokine kits (Millipore, Billerica, MA). Quantities of PGE2,a n d
PGF2a were determined using commercially available human
ELISA EIA kits (Cayman Chemical, Ann Arbor, MI). Values were
converted to pg/ml by comparison to a standard curve.
Analysis of matrix metalloproteinase activity was performed on
amniotic fluid sampled and stored as described above using P126
(BioMol,PlymouthMeeting,PA),aMMP fluorogenicsubstrate[Mca-
Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2?AcOH, Mca=(7-methoxycou-
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pionyl]. Briefly, samples were diluted in activity buffer (500 mM
HEPES, 100 mM CaCl2, 0.05% w/v Brij-35, pH 7), pre-warmed to
37uC, and added to the fluorogenic substrate (10 mM). Quantification
of the activity (pmol/min) was achieved using a standard curve
generated with the cleaved fluorogenic product, P127 (BioMol,
Plymouth Meeting, PA). Plate fluorescence (Ex.: 328 nm, Em.:
393 nm) was measured serially for four hours at 37uC and a standard
curve generated of the cleaved fluorogenic product (P127; pmol/min).
The units of total MMP activity are reported as pmol/min of cleaved
product. Positive controls were run for each plate with either human
recombinant MMP-9 or lysed fibroblasts.
Quantitative Real-Time PCR
All primers were designed using Primer 3 software (Whitehead
Institute for Biomedical Research, NJ). A standard curve was
prepared by amplifying CPSHIII sequence specific to the GBS
strain, COH1. First, genomic DNA was purified from 500 mLo f
overnight GBS culture in TSB using the Gentra Puregene Yeast/
Bact. Kit (Qiagen, Valencia, CA). Primers, 59-CTT TGG AAG
AGT GAG TTA G-39 and 59-TGA CCA ATT AGT GTA GCA
TA-39, were used to generate a 389-bp product from the CPSHIII
sequence [55]. The PCR amplification was performed in 25 mL
reactions using MyTaq (Bioline, Taunton, MA, USA). The PCR
conditions were as follows: initial DNA denaturation at 95uC for
60 sec followed by 35 cycles of 95uC for 30 s, 52uC for 30 sec, and
72uC for 40 sec. Primer specificity and quality was confirmed by
gel electrophoresis of 5 mL PCR product on 1.5% agarose gel,
stained with 0.02 mg/mL ethidium bromide. The PCR product
was purified using MinElute Reaction Cleanup Kit (Qiagen,
Valencia, CA) and the concentration was determined by
Nanodrop. Amplicon concentration (amp/mL) was determined
using the molecular weight of amplified product calculated with
sequence manipulation suite and the DNA concentration [56].
For quantitative real-time PCR, 500 mL of amniotic fluid was
centrifuged at 15,0006g for 5 minutes. Supernatant was removed
and the pellet resuspended in 40 mL of cell lysis buffer (20% sucrose,
10 mMMgCl,20 mMTrispH 7.0,0.05%TritonX-100,0.5units/
mL mutanolysin). Cells were lysed at 37uC for 2–3 hours.
Quantitative real-time PCR was conducted in 25 mLr e a c t i o n s
consisting of 5 mL of above cell lysate, respective standard, or PCR-
grade water (Ambion,Austin, TX); 0.25 mMp r i m e r s :5 9-CAG TTG
TAA GGA ATG TGG TAA AGG-39 and 59-AAA GTT GGC
TTC AGC ATA GG-39;a n d1 6SensiMix SYBR and Fluoroscein
qRT-PCRKit Mix (Bioline, Taunton, MA). A 500 seq/mLs t a n d a r d
and 1,000 CFU/mL were used as positive controls for unknowns.
The reaction conditions were as follows: DNA was denatured at
95uC for 10 minutes followed by 40 cycles at 95uC for 15 seconds,
55uC for 15 seconds, and 72uC for 15 seconds. Specificityof primers
was confirmed with melting curve of product and gel electrophoresis
with 10 mL of reaction product on a 2% agarose gel.
Statistical Analysis
Study outcomes were quantities of uterine activity (mean 24-
hour HCA), cytokines in amniotic fluid and fetal plasma (IL-1b,
TNF-a, IL-6, IL-8), and amniotic fluid prostaglandins (PGE2,
PGF2a) and matrix metalloproteinases (total MMP activity). Data
was transformed by natural logarithm prior to analysis with the
exception of matrix metalloproteinase data. We used one-way
analysis of variance (ANOVA) to assess differences between the
control and GBS groups with respect to each outcome. IL-1b and
TNF-a in fetal plasma could not be assessed due to a large number
of 0 values. All statistical analyses were conducted using
Intercooled STATA 8.2 for Windows 2000 (StatCorp, College
Station, TX). Significance was considered at p,0.05.
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